Gonadotropin-releasing hormone-agonist as a neoadjuvant therapy for Sertoli–Leydig cell tumors of the ovary

Saved in:
Bibliographic Details
Published inInternational journal of gynecology and obstetrics Vol. 66; no. 2; pp. 189 - 190
Main Authors Chao, H.T., Wang, P.H., Lin, H.D.
Format Journal Article
LanguageEnglish
Published Shannon Elsevier Ireland Ltd 01.08.1999
Elsevier Science
Subjects
Aged
Androgen-secreting ovarian tumor
Antineoplastic Agents, Hormonal - therapeutic use
Biological and medical sciences
Female
Female genital diseases
Genital system. Reproduction
Gonadotropin-Releasing Hormone - agonists
Gonadotropin-releasing hormone agonist
Gynecology. Andrology. Obstetrics
Humans
Medical sciences
Neoadjuvant therapy
Neoplasms, Hormone-Dependent - diagnosis
Neoplasms, Hormone-Dependent - drug therapy
Ovarian Neoplasms - diagnosis
Ovarian Neoplasms - drug therapy
Pharmacology. Drug treatments
Sertoli-Leydig Cell Tumor - diagnosis
Sertoli-Leydig Cell Tumor - drug therapy
Tumors
Asia
Taiwan
Neoadjuvant therapy
Gonadotropin-releasing hormone agonist
Androgen-secreting ovarian tumor
Human
Sertoli cell
Agonist
Androgen
Gonadotropin RH
Female genital diseases
Case study
Ovarian diseases
Ovary
Chemotherapy
Treatment
Virilism
Female
Diagnosis
Benign neoplasm
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0020-7292
1879-3479
DOI:10.1016/S0020-7292(99)00071-5